Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Spectral Medical (EDTXF)
OTHER OTC:EDTXF
Holding EDTXF?
Track your performance easily
EDTXF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.28 - $0.55
Previous Close$0.32
Volume120.28K
Average Volume (3M)12.74K
Market Cap
$93.68M
Enterprise Value$89.04M
Total Cash (Recent Filing)C$7.54M
Total Debt (Recent Filing)C$895.00K
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding279,466,079
10 Day Avg. Volume15,447
30 Day Avg. Volume12,738
Standard Deviation0.17
R-Squared0.07
Alpha0.00091
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)69.83
Price to Cash Flow (P/CF)-13.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Spectral Medical News
PremiumCompany Announcements
Spectral Medical Advances Amid Tigris Trial Challenges
PremiumCompany Announcements
Spectral Medical Advances with Tigris Trial Progress
PremiumCompany Announcements
Spectral Medical Nears Completion of Tigris Trial
PremiumCompany Announcements
Spectral Medical Nears Tigris Trial Completion
PremiumCompany Announcements
Spectral Medical Nears Tigris Trial Completion
PremiumCompany Announcements
Spectral Medical Approaches Tigris Trial CompletionPremiumCompany Announcements
Spectral Medical Nears Tigris Trial Completion
PremiumCompany Announcements
Spectral Medical Strengthens Funds with Convertible NotesOptions Prices
Currently, No data available
---
Ownership Overview
1.95% Insiders
<0.01% Other Institutional Investors
98.04% Public Companies and
Individual Investors
EDTXF FAQ
What was Spectral Medical’s price range in the past 12 months?
Spectral Medical lowest stock price was $0.28 and its highest was $0.55 in the past 12 months.
What is Spectral Medical’s market cap?
Currently, no data Available
When is Spectral Medical’s upcoming earnings report date?
Spectral Medical’s upcoming earnings report date is Mar 27, 2025 which is in 94 days.
How were Spectral Medical’s earnings last quarter?
Spectral Medical released its earnings results on Nov 08, 2024. The company reported -$0.028 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.028.
Is Spectral Medical overvalued?
According to Wall Street analysts Spectral Medical’s price is currently Overvalued.
Does Spectral Medical pay dividends?
Spectral Medical does not currently pay dividends.
What is Spectral Medical’s EPS estimate?
Spectral Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spectral Medical have?
Spectral Medical has 282,842,380 shares outstanding.
What happened to Spectral Medical’s price movement after its last earnings report?
Spectral Medical reported an EPS of -$0.028 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.5%.
Which hedge fund is a major shareholder of Spectral Medical?
Currently, no hedge funds are holding shares in EDTXF
---
Spectral Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
10.68%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-5.63%
Trailing 12-Months
Company Description
Spectral Medical
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include Endotoxin Activity Assay (EAA), Toraymyxin, and proprietary reagents. The EAA is use for the diagnostic of endotoxin activity in human whole blood. The Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada.
---
Technical Analysis
---